Dronedarone
Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
---|---|---|---|
Antiarrhythmics | Dronedarone | 400mg PO Q12H | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
---|---|---|---|---|---|---|---|
557 | 6 (mainly as metabolites) | 13-19 | N/A | >98 | 20 (based on 70 kg) | N/A | N/A |
References:
- Dronedarone. In:Lexi-Drugs Online. Hudson (OH): Lexi-Comp, Inc,; [updated 04/23/12; accessed 04/23/12].
- Drug Future [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugfuture.com/chemdata/dronedarone.html